Brawn Biotech Ltd

NSE: BRAWN · BSE: 530207 · Pharmaceuticals & Biotechnology · 11 announcements

Share price: ₹25.50
Market cap: ₹7.65 Cr
Revenue (annual): ₹16.98 Cr
Net profit (annual): ₹0.94 Cr
P/E (TTM): 8.9×Sector 47.3×
Promoter holding: 52.94%+0.00% QoQ
FII holding: 0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Financial Results 4 Other Announcement 3 Board Meeting Date 2 Debt & Borrowing 1 Annual General Meeting 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

2 announcements with these filters

5 Aug 2026 16:57 IST BSE

Board Meeting Date

Brawn Biotech Board Meeting Date

Brawn Biotech Ltd has scheduled a Board Meeting for August 13, 2026, to consider and approve the unaudited financial results for the quarter ended June 30, 2026.

Read the filing ↗

21 May 2026 12:50 IST BSE

Board Meeting Date

Brawn Biotech Board Meeting Date

Brawn Biotech scheduled a board meeting for May 29, 2026, to approve audited FY2026 financial results. The trading window remains closed until June 1, 2026.

Read the filing ↗